Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1992;70(4):515–526.

HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.

M C Raviglione 1, J P Narain 1, A Kochi 1
PMCID: PMC2393393  PMID: 1394786

Abstract

This article reviews the clinical aspects and diagnosis of HIV-associated tuberculosis in developing countries, and summarizes WHO's recommendations for treatment. According to WHO estimates (early 1992) over 4 million persons worldwide have been infected with HIV and tuberculosis; 95% of them are in the developing countries. Clinical features of HIV-associated pulmonary tuberculosis in adults are frequently atypical, particularly in the late stage of HIV infection, with non-cavitary disease, lower lobe infiltrates, hilar lymphadenopathy and pleural effusion. More typical post-primary tuberculosis with upper lobe infiltrates and cavitations is seen in the earlier stages of HIV infection. Extrapulmonary tuberculosis is reported more frequently, despite the difficulties in diagnosing it. WHO's recent guidelines recommend 6-month short-course chemotherapy with isoniazid, rifampicin, pyrazinamide and ethambutol for patients with HIV-associated tuberculosis. The older 12-month regimen without rifampicin is much less effective. Streptomycin should not be used, because of the risk of transmitting blood-borne pathogens through contaminated needles. Thioacetazone should be abandoned, because of severe adverse reactions observed among HIV-infected patients. The roles of preventive chemotherapy and BCG vaccination for prevention of tuberculosis are also briefly discussed.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cathebras P., Vohito J. A., Yete M. L., Lagarde R., Vohito M. D., Ramiara J. P., Mbolidi C. D., Nama J., Ngbali J., Siopathis M. R. Tuberculose et infection par le virus de l'immunodéficience humaine en République Centrafricaine. Med Trop (Mars) 1988 Oct-Dec;48(4):401–407. [PubMed] [Google Scholar]
  2. Cegielski J. P., Ramiya K., Lallinger G. J., Mtulia I. A., Mbaga I. M. Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet. 1990 Jan 27;335(8683):209–212. doi: 10.1016/0140-6736(90)90288-g. [DOI] [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) BCG vaccination and pediatric HIV infection--Rwanda, 1988-1990. MMWR Morb Mortal Wkly Rep. 1991 Dec 6;40(48):833–836. [PubMed] [Google Scholar]
  4. Centers for Disease Control (CDC) Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep. 1989 Apr 14;38(14):236-8, 243-50. [PubMed] [Google Scholar]
  5. Colebunders R. L., Lebughe I., Nzila N., Kalunga D., Francis H., Ryder R., Piot P. Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire. J Acquir Immune Defic Syndr. 1989;2(6):576–578. [PubMed] [Google Scholar]
  6. Colebunders R. L., Ryder R. W., Nzilambi N., Dikilu K., Willame J. C., Kaboto M., Bagala N., Jeugmans J., Muepu K., Francis H. L. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Respir Dis. 1989 May;139(5):1082–1085. doi: 10.1164/ajrccm/139.5.1082. [DOI] [PubMed] [Google Scholar]
  7. Daniel T. M. Rapid diagnosis of tuberculosis: laboratory techniques applicable in developing countries. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S471–S478. doi: 10.1093/clinids/11.supplement_2.s471. [DOI] [PubMed] [Google Scholar]
  8. De Cock K. M., Gnaore E., Adjorlolo G., Braun M. M., Lafontaine M. F., Yesso G., Bretton G., Coulibaly I. M., Gershy-Damet G. M., Bretton R. Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. BMJ. 1991 Mar 2;302(6775):496–499. doi: 10.1136/bmj.302.6775.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elliott A. M., Luo N., Tembo G., Halwiindi B., Steenbergen G., Machiels L., Pobee J., Nunn P., Hayes R. J., McAdam K. P. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ. 1990 Sep 1;301(6749):412–415. doi: 10.1136/bmj.301.6749.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FitzGerald J. M., Grzybowski S., Allen E. A. The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest. 1991 Jul;100(1):191–200. doi: 10.1378/chest.100.1.191. [DOI] [PubMed] [Google Scholar]
  11. Gilks C. F., Brindle R. J., Otieno L. S., Bhatt S. M., Newnham R. S., Simani P. M., Lule G. N., Okelo G. B., Watkins W. M., Waiyaki P. G. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS. 1990 Oct;4(10):981–985. doi: 10.1097/00002030-199010000-00006. [DOI] [PubMed] [Google Scholar]
  12. Harries A. D. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990 Feb 17;335(8686):387–390. doi: 10.1016/0140-6736(90)90216-r. [DOI] [PubMed] [Google Scholar]
  13. Jordan T. J., Lewit E. M., Montgomery R. L., Reichman L. B. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis. JAMA. 1991 Jun 12;265(22):2987–2991. [PubMed] [Google Scholar]
  14. Kadende P., Standaert B., Niragira F., Kamamfu G., Laroche R. S.I.D.A. tropical et tuberculose. A propos d'une enquête menée à Bujumbura dans l'entourage direct de tuberculeux séropositifs et séronégatifs pour le virus HIV. Med Trop (Mars) 1988 Jan-Mar;48(1):19–20. [PubMed] [Google Scholar]
  15. Kelly P., Burnham G., Radford C. HIV seropositivity and tuberculosis in a rural Malawi hospital. Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):725–727. doi: 10.1016/0035-9203(90)90165-b. [DOI] [PubMed] [Google Scholar]
  16. Kool H. E., Bloemkolk D., Reeve P. A., Danner S. A. HIV seropositivity and tuberculosis in a large general hospital in Malawi. Trop Geogr Med. 1990 Apr;42(2):128–132. [PubMed] [Google Scholar]
  17. Lallemant-Le Coeur S., Lallemant M., Cheynier D., Nzingoula S., Drucker J., Larouze B. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers. AIDS. 1991 Feb;5(2):195–199. doi: 10.1097/00002030-199102000-00010. [DOI] [PubMed] [Google Scholar]
  18. Lesbordes J. L., Baquillon G., Georges M. C., Ngbali J., Georges A. J. La tuberculose au cours de l'infection par le virus de l'immunodéficience humaine (VIH) à Bangui (République centrafricaine). Med Trop (Mars) 1988 Jan-Mar;48(1):21–25. [PubMed] [Google Scholar]
  19. Long R., Maycher B., Scalcini M., Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest. 1991 Jan;99(1):123–127. doi: 10.1378/chest.99.1.123. [DOI] [PubMed] [Google Scholar]
  20. Mbaga J. M., Pallangyo K. J., Bakari M., Aris E. A. Survival time of patients with acquired immune deficiency syndrome: experience with 274 patients in Dar-es-Salaam. East Afr Med J. 1990 Feb;67(2):95–99. [PubMed] [Google Scholar]
  21. Nambuya A., Sewankambo N., Mugerwa J., Goodgame R., Lucas S. Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda. J Clin Pathol. 1988 Jan;41(1):93–96. doi: 10.1136/jcp.41.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pang J. A., Chan H. S., Chan C. Y., Cheung S. W., French G. L. A tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis. A prospective study of bronchoscopic aspirate and lavage specimens. Ann Intern Med. 1989 Oct 15;111(8):650–654. doi: 10.7326/0003-4819-111-8-650. [DOI] [PubMed] [Google Scholar]
  23. Pape J. W., Liautaud B., Thomas F., Mathurin J. R., St Amand M. M., Boncy M., Pean V., Pamphile M., Laroche A. C., Johnson W. D., Jr Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N Engl J Med. 1983 Oct 20;309(16):945–950. doi: 10.1056/NEJM198310203091603. [DOI] [PubMed] [Google Scholar]
  24. Perriëns J. H., Colebunders R. L., Karahunga C., Willame J. C., Jeugmans J., Kaboto M., Mukadi Y., Pauwels P., Ryder R. W., Prignot J. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis. 1991 Oct;144(4):750–755. doi: 10.1164/ajrccm/144.4.750. [DOI] [PubMed] [Google Scholar]
  25. Rieder H. L., Cauthen G. M., Comstock G. W., Snider D. E., Jr Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79–98. doi: 10.1093/oxfordjournals.epirev.a036046. [DOI] [PubMed] [Google Scholar]
  26. Standaert B., Niragira F., Kadende P., Piot P. The association of tuberculosis and HIV infection in Burundi. AIDS Res Hum Retroviruses. 1989 Apr;5(2):247–251. doi: 10.1089/aid.1989.5.247. [DOI] [PubMed] [Google Scholar]
  27. Sudre P., ten Dam G., Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70(2):149–159. [PMC free article] [PubMed] [Google Scholar]
  28. Tsega E. The demographic, social and clinical presentations of one hundred Ethiopian patients with human immunodeficiency virus (HIV) infection. Ethiop Med J. 1990 Apr;28(2):81–88. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES